Marshall Wace’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,900
| Closed | -$1.6M | – | 3584 |
|
|
2022
Q3 | $1.6M | Sell |
30,900
-1,148,048
| -97% | -$59.3M | ﹤0.01% | 1638 |
|
|
2022
Q2 | $29.2M | Sell |
1,178,948
-219,635
| -16% | -$5.44M | 0.06% | 300 |
|
|
2022
Q1 | $35.1M | Buy |
1,398,583
+569,585
| +69% | +$14.3M | 0.07% | 301 |
|
|
2021
Q4 | $30.2M | Buy |
+828,998
| New | +$30.2M | 0.06% | 324 |
|
|
2020
Q3 | – | Sell |
-121,003
| Closed | -$6.96M | – | 1988 |
|
|
2020
Q2 | $6.96M | Buy |
121,003
+108,919
| +901% | +$6.27M | 0.05% | 366 |
|
|
2020
Q1 | $486K | Sell |
12,084
-40,186
| -77% | -$1.62M | ﹤0.01% | 973 |
|
|
2019
Q4 | $2.07M | Buy |
+52,270
| New | +$2.07M | 0.01% | 766 |
|
|
2019
Q2 | – | Sell |
-132,410
| Closed | -$1.84M | – | 1950 |
|
|
2019
Q1 | $1.84M | Buy |
+132,410
| New | +$1.84M | 0.02% | 758 |
|
|
2015
Q4 | – | Sell |
-282,713
| Closed | -$1.71M | – | 1170 |
|
|
2015
Q3 | $1.71M | Hold |
282,713
| – | – | 0.02% | 492 |
|
|
2015
Q2 | $2.33M | Buy |
282,713
+55,055
| +24% | +$453K | 0.03% | 441 |
|
|
2015
Q1 | $1.72M | Buy |
+227,658
| New | +$1.72M | 0.02% | 494 |
|
|
2014
Q3 | – | Sell |
-98,298
| Closed | -$575K | – | 1091 |
|
|
2014
Q2 | $575K | Buy |
+98,298
| New | +$575K | 0.01% | 581 |
|